Presenters
The March 31, 2020, IAS-USA Webinar titled, The Elements of Taking a Sexual History, which was to be presented by Dr Allison Agwu, is postponed. While you wait for this webinar to be rescheduled, you may view the following webcast presented by Dr Agwu regarding sexual health here.
A number of our faculty members have been actively responding to the COVID-19 pandemic. Understanding this pandemic, preparing the response, and providing patient care is the number 1 priority at this point. Foremost, we hope all of them, and all of you, your patients, your colleagues, and your communities, stay healthy and safe.
Please visit https://www.iasusa.org for updates on postponed and rescheduled courses and activities, including the rescheduled webinars.
Overview
Assessment of Needs
The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians.
Taking a sexual history from patients is a necessary first step towards providing necessary counseling. A sexual history allows clinicians to identify those individuals at risk for STIs, including HIV. This webinar will provide an updated approach in taking a sexual history.
Learning Objectives
Upon completion of this webinar, learners will be able to:
- List important aspects of a detailed sexual history, including sexual and gender minorities
- Identify approaches to improving sexual health
Registration
Who Should Attend
This advanced webinar is designed for clinical decision makers who are actively involved in sexual health care. It is also relevant for registered nurses, PharmDs, and other health professionals.
Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.
Registration closes on Monday, March 30, 2020, 4:00 PM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”
Continuing Education Credits
CME Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits
This activity is eligible for ANCC credit; see the final CNE activity announcement for specific details.
Pharmacy Credits
This activity is eligible for ACPE credit; see the final CPE activity announcement for specific details.
Grant Support
This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.
PLATINUM SUPPORTERS
Gilead Sciences, Inc
Merck & Co, Inc
ViiV Healthcare
SILVER SUPPORTER
Janssen Therapeutics
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.